Genomictree Inc. (228760) — Financial Flexibility Index
Genomictree Inc. (228760) has a Financial Flexibility Index of -0.58x as of December 2025. Free cash flow of ₩-3.15 Billion (operating CF ₩-3.21 Billion minus capex ₩62.29 Million) represents -1% of total liabilities (₩5.45 Billion). Check 228760 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Genomictree Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Genomictree Inc. across 6 annual periods. See Genomictree Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Genomictree Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Genomictree Inc.. For the full company profile including market capitalisation, see 228760 market cap overview.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.37x | ₩-7.45 Billion | ₩-10.19 Billion | ₩5.45 Billion | ▲ +21.7% |
| 2024 | -1.74x | ₩-11.08 Billion | ₩-13.63 Billion | ₩6.36 Billion | ▼ -28.6% |
| 2023 | -1.36x | ₩-10.59 Billion | ₩-10.88 Billion | ₩7.81 Billion | ▼ -1339.5% |
| 2022 | 0.11x | ₩6.11 Billion | ₩4.29 Billion | ₩55.86 Billion | ▲ +61.7% |
| 2021 | 0.07x | ₩4.20 Billion | ₩-7.63 Billion | ₩62.05 Billion | ▲ +120.4% |
| 2020 | -0.33x | ₩-7.50 Billion | ₩-10.19 Billion | ₩22.64 Billion | — |